Investors Land KITE Even Cheaper Than Its Secondary Stock Offering
March 06, 2017 at 10:19 AM EST
Looking back to 4 days ago, Kite Pharma Inc (KITE) priced a 4,750,000 share secondary stock offering at $75.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
